Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Rating of “Buy” from Analysts

Simulations Plus, Inc. (NASDAQ:SLP) has earned an average rating of “Buy” from the seven ratings firms that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $49.40.

SLP has been the subject of a number of analyst reports. KeyCorp lifted their price objective on shares of Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Stephens initiated coverage on shares of Simulations Plus in a research report on Friday, November 15th. They issued an “overweight” rating and a $39.00 price objective for the company. Finally, William Blair reissued an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th.

Insider Buying and Selling

In related news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $33.91, for a total transaction of $678,200.00. Following the completion of the sale, the director now owns 3,402,584 shares of the company’s stock, valued at approximately $115,381,623.44. The trade was a 0.58 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 19.40% of the stock is currently owned by insiders.

Institutional Trading of Simulations Plus

Several hedge funds and other institutional investors have recently bought and sold shares of SLP. Janus Henderson Group PLC raised its stake in Simulations Plus by 7,753.3% in the 4th quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company’s stock worth $15,141,000 after purchasing an additional 535,986 shares in the last quarter. Conestoga Capital Advisors LLC raised its stake in Simulations Plus by 15.0% in the 4th quarter. Conestoga Capital Advisors LLC now owns 2,226,262 shares of the technology company’s stock worth $62,090,000 after purchasing an additional 290,414 shares in the last quarter. Royce & Associates LP raised its stake in Simulations Plus by 56.6% in the 4th quarter. Royce & Associates LP now owns 371,797 shares of the technology company’s stock worth $10,369,000 after purchasing an additional 134,381 shares in the last quarter. Nicholas Company Inc. acquired a new stake in Simulations Plus in the 4th quarter worth about $3,418,000. Finally, Kennedy Capital Management LLC raised its stake in Simulations Plus by 59.4% in the 4th quarter. Kennedy Capital Management LLC now owns 289,286 shares of the technology company’s stock worth $8,068,000 after purchasing an additional 107,766 shares in the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.

Simulations Plus Trading Up 1.0 %

Simulations Plus stock opened at $28.82 on Wednesday. The company has a market cap of $579.05 million, a P/E ratio of 72.05 and a beta of 0.83. Simulations Plus has a 1-year low of $24.00 and a 1-year high of $51.22. The company has a fifty day simple moving average of $31.79 and a 200 day simple moving average of $31.75.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.